C indications treatment of iron deficiency anemia in adults who cannot toleratehave an unsatisfactory response to oral iron or who have chronic kidney disease nondialysis dependent. Ferric carboxymaltose api manufacturers suppliers drug. This formulation isolates the iron from the plasma until the complex is phagocytized by reticuloendothelial system macrophages in the liver, spleen and bone marrow. Ferric carboxymaltose fcm has a complex carbohydrate shell that tightly binds elemental iron and, as a result, can be given in larger doses via slow iv push or infused over 15 minutes. Injectafer ferric carboxymaltose injection is an iron replacement product indicated for the treatment of iron deficiency anemia ida in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, or in adult patients with nondialysis dependent chronic kidney disease. Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. Ferric carboxymaltose anemia heart failure free 30day. Ferinject ferric carboxymaltose summary of product. Ferric carboxymaltose ferinject for irondeficiency. Each vial of ferinject is intended for single use only. Ferric carboxymaltose ferrik carboxeemoltoes is an iron complex. Ferric carboxymaltose in patients with heart failure and.
Iron is a mineral that the body needs to produce red blood cells. Apr 24, 2020 ferinject ferric carboxymaltose patient information leaflet pil by vifor pharma uk limited. Each 10 ml vial contains 500 mg of iron as ferric carboxymaltose. Injectafer should be used only if you have not responded well to treatment with oral iron, or if you are intolerant to oral iron treatment. Ferric carboxymaltose free download as powerpoint presentation. Overview final guidance geneesmiddeleninformatiebank. Ferric carboxymaltose solutions containing 24 mgml of iron in 0. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron.
Ferric carboxymaltose anemia heart failure free 30. Intravenous ferric carboxymaltose for the treatment of iron deficiency. Common and rare side effects for ferric carboxymaltose. Ferric carboxymaltose similar also increased significantly oxidativenitrosative stress, proinflammatory, and apoptosis markers in the liver, heart and kidneys versus iron sucrose originator. Use ferric carboxymaltose as ordered by your doctor. Ferric carboxymaltose injection comes as a solution liquid to inject intravenously into a vein by a doctor or nurse in a medical office or hospital outpatient clinic. Ferinject ferric carboxymaltose 50 mgml solution for injection. Ferric carboxymaltose patents expiry expiration dates.
Each 2 ml vial contains 100 mg of iron as ferric carboxymaltose. This draft guidance, when finalized, will represent the current thinking of the food and drug. Ep2496595a2 process for the preparation of iron iii. Pharmacokinetics of ferric bepectatea new intravenous iron. Pediatric pharmacotherapy university of virginia school. What is injectafer ferric carboxymaltose injection. The iron is then released into an intracellular storage iron pool or. Administration of ferric carboxymaltose to rats as a onehour intravenous infusion up to 30 mgkgday iron on gestation days 6 to 17 did not result in adverse embryonic or fetal findings. Ferric carboxymaltose injection is an iron replacement product that is used to treat iron deficiency anemia not enough iron in the blood in patients with nondialysis dependent chronic kidney disease ckd, and in patients who are taking iron supplements that did not work well iron is a mineral that the body needs to produce red blood cells. Encicarb injection contains elemental iron as an active ingredient. Thus, for example, heating a mixture of one or more maltodextrins, ferric hydroxide and water, oxidizing the iron maltodextrin complex obtained using an aqueous sodium hypochlorite solution and maintaining at 25c to 125c to obtain iron iii carboxymaltose complex. Injectafer ferric carboxymaltose dose, indications. Prevention may also be used in low birth weight babies.
Feb 27, 2020 injectafer ferric carboxymaltose injection is a dark brown, sterile, aqueous, isotonic colloidal solution for intravenous injection. Injectafer ferric carboxymaltose dose, indications, adverse. Feb 01, 2020 ferric carboxymaltose is a colloidal iron iii hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron. Randomized, placebocontrolled trial of ferric carboxymaltose. Effects of iron isomaltoside vs ferric carboxymaltose on. Possible side effects nausea feeling dizzy low phosphorus skin flushing.
Intravenous ferric carboxymaltose for the treatment of. It is given as an infusion into a vein over a period of time. Ferinject 50mg ironml solution for injectioninfusion contains ferric. Fcm permits single dose, short 15minute infusions, and higher dosing up to mg, making it an attractive alternative in terms of safety, efficacy, convenience, and resource utilization 6 9. Nov 09, 2018 ferric carboxymaltose is an iron replacement product. Pdf the pharmacology and safety profile of ferric carboxymaltose. Injectafer is injected into your vein to treat iron deficiency anemia in adults.
Use only those containing sedimentfree, homogeneous solution. This ed material has been downloaded from a licensed data provider and is not for distribution, except. Ferric carboxymaltose is an intravenous iron preparation that can be delivered by. Injectafer is indicated for the treatment of iron deficiency anemia in adult patients. Fcm can correct irondeficiency anaemia ida across a range of clinical conditions, with efficacy and tolerability similar to those of iv. Your doctor will also check your blood pressure frequently during this time. Thus, for example, a mixture of one or more maltodextrins, ferric hydroxide and water is heated, the resulting iron maltodextrin complex is oxidized using an aqueous sodium hypochlorite solution, followed by maintaining at 25 c. The role of ferric carboxymaltose in the treatment of iron deficiency. Iron sucrose and ferric carboxymaltose fcm are dextranfree iv iron alternatives. Each ml contains 50 mg iron as ferric carboxymaltose in water for injection. Ferric carboxymaltose intravenous route description and. If your iron levels become low after you finish your treatment, your doctor may prescribe this.
In many cases, use of intravenous iron such as ferric carboxymaltose has lower risks of adverse events than a blood transfusion and as long as the person is stable is a better alternative. Fcm is a parenteral iron dextranfree product and the first of the new agents approved for rapid and highdose. Ferric carboxymaltose 2 qualitative and quantitative composition. Encicarb ferric carboxymaltose price in india, emcure.
Pharmacokinetics of ferric bepectatea new intravenous. Ferric carboxymaltose side effects, dosage, interactions. Ferric carboxymaltose is administered intravenously. This medicine is used to treat anemia in people with chronic kidney disease or people who cannot take iron by mouth. Spontaneous abortions occurred starting at the daily. Intravenous ferric carboxymaltose for the treatment of iron. Ferric carboxymaltose can improve hb levels and iron stores for irondeficiency anaemia associated with a variety of conditions prospective trials have demonstrated efficacy in patients with inflammatory bowel disease, chronic kidney disease, menorrhagia and postpartum anaemia. Intravenous iron formulations such as ferric carboxymaltose, iron dextran, ferric gluconate, and iron sucrose may potentially solve these issues and may be more convenient both to healthcare providers and patients, if oral iron therapy does not provide the required correction of iron deficiency or is not welltolerated by patients 4, 6, 9. It is usually given as a total of 2 doses, spaced at least 7 days apart. Malformations were seen starting at the daily dose of 9 mgkg 23% of the human weekly dose of 750 mg.
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia. Mar 02, 2011 hypophosphatemia with ferric carboxymaltose vs. Fcm permits single dose, short 15minute infusions, and higher dosing up to mg, making it an attractive alternative in terms of safety, efficacy, convenience, and resource utilization 69. Ferric carboxymaltose inj encicarb by emcure is a medicine that is used for the treatment of iron deficiencies, anemia and other conditions. Iron dextran in iron deficiency secondary to heavy uterine bleeding the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Jul 11, 2016 randomized, placebocontrolled trial of ferric carboxymaltose in rls patients with irondeficiency anemia the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Ferric carboxymaltose definition of ferric carboxymaltose. Two are currently approved for use in europeferric carboxymaltose and. Injectafer ferric carboxymaltose injection is indicated for the treatment of iron deficiency anemia ida in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, or who have nondialysis dependent chronic kidney disease. Rbc uptake of iron released from ferric carboxymaltose ranges between 6199%.
Ferric carboxymaltose elevates hb level and restores iron stores faster than iv iron sucrose and oral iron. Ferric carboxymaltose in heart failure and iron deficiency n engl j med 361. This prospective randomized controlled study involved 58 subjects. Us20120214986a1 process for the preparation of iron iii. Drug name active ingredients strength dosage formroute marketing status te code rld rs. Each of the side effects above was reported in 2% or greater of patients treated with ferric. Ferinject ferric carboxymaltose patient information.
Intravenous ferric carboxymaltose for anaemia in pregnancy. Each 20 ml vial contains mg of iron as ferric carboxymaltose. Ferric carboxymaltose injection is an iron replacement product that is used to treat iron deficiency anemia not enough iron in the blood in patients with nondialysis dependent chronic kidney disease ckd, and in patients who are taking iron supplements that did not work well. It is freely soluble in water but insoluble in most organic solvents. Fcm is a parenteral iron dextran free product and the first of the new agents approved for rapid and highdose replenishment of depleted iron stores. Group f received mg intravenous ferric carboxymaltose and group c received normal saline. After administration of a single dose of ferric carboxymaltose of 100 mg of iron in iron deficient patients, the iron was rapidly cleared from the plasma with a terminal halflife of 712 hours. The injectafer savings program helps patients being treated with injectafer with their prescription out of pocket responsibility. Nov 12, 2019 iron sucrose and ferric carboxymaltose fcm are dextran free iv iron alternatives. This medicine is used to treat anemia in people with chronic kidney disease or people who. Injectafer ferric carboxymaltose dosing, indications. Injectafer is a prescription iron replacement medicine administered only by or under the supervision of your healthcare provider.
This study assessed the efficacy of intraoperative highdose intravenous iron therapy in facilitating recovery from postoperative anemia and reducing the transfusion rate in patients with total knee and total hip arthroplasty. It works as a dietary supplement to fulfill the iron deficiencies and regulate oxygen in the blood. Ferric carboxymaltose injection may cause severe or lifethreatening reactions during and shortly after you receive the medication. The present invention related to novel processes for the preparation of iron iii carboxymaltose complex. In rabbits, ferric carboxymaltose was administered. It was approved in europe in 2007 and by the fda in 20 for use in adults with an intolerance of or inadequate response to oral iron therapy and in. Ferric carboxymaltose fcm is a novel dextranfree intravenous iron which.
Ferric carboxymaltose is a brown, amorphous powder. The most commonly reported adverse drug reactions adr during. It contains 24 32% mm of iron, 2550% mm of dextrin, some sodium chloride ferric carboxymaltose as a complex of polynuclear ironiii hydroxide. Administration of ferric carboxymaltose to rats as a onehour intravenous infusion up to 30 mgkgday iron on gestation days 6 to 17 did not result in adverse embryofetal findings. Ferric carboxymaltose fcm is a parenteral iron preparation with characteristics that allow larger single doses to be administered over a shorter infusion period compared with existing iv iron preparations. Letter to editor sakiyeva kanshaiym, a gulmira zhurabekova, a ibrahim a. Pdf the objective of the present study is to compare the safety and efficacy of ferric carboxymaltose. Selected from data included with permission and ed by first databank, inc. In rabbits, ferric carboxymaltose was administered as a. Oct 11, 2019 how is this medicine ferric carboxymaltose best taken. Ferric carboxymaltose is a colloidal iron hydroxide carboxymaltose complex. In animal reproduction studies, administration of ferric carboxymaltose to rabbits during the period of organogenesis caused adverse developmental outcomes including fetal malformations and increased implantation loss at maternally toxic doses of approximately 12% to 23% of the human weekly dose of 750 mg based on body surface area.
Patents listed in the fda orange book drug database of ferric carboxymaltose with information and expiryexpiration dates. Ferric carboxymaltose is used to treat anemia low red blood cells caused by low iron levels. Ferric carboxymaltose is a form of injectable iron that is used if you cannot take iron by mouth because of side effects or an unsuccessful response to treatment. This daily dose in rats is approximately 40% of the human weekly dose of 750 mg based on body surface area. Free iron, present as a result of iron overload, may have an adverse effect on. Iron helps your body produce red blood cells that carry oxygen through your blood to tissues and. Your doctor will watch you carefully while you receive each dose of ferric carboxymaltose injection and for at least 30 minutes afterwards. The present invention relates to novel processes for the preparation of iron iii carboxymaltose complex. Dailymed injectafer ferric carboxymaltose injection. Ultimately this always remains a clinical decision based on local guidelines, although national guidelines are increasingly stipulating iv iron in certain. In rabbits, ferric carboxymaltose was administered as a onehour infusion on gestation days 6 to 19 at iron doses of 4.
Ferric carboxymaltose ferinject for irondeficiency anaemia. Pediatric pharmacotherapy university of virginia school of. Contains nonbinding recommendations draft guidance on ferric carboxymaltose recommended apr 2016 this draft guidance, when finalized, will represent the current thinking of the food and drug. Because intravenous iv iron can induce hypophosphatemia, the 2 clinical trials in this report directly compare the effects of 2 iv iron formulations, iron isomaltoside now known as ferric derisomaltose and ferric carboxymaltose, on phosphate levels in patients with irondeficiency anemia. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Children with intestinal failure if who are treated with ironfree parenteral nutrition pn are at risk for developing iron deficiency id. Iron deficiency anemia ida is the most common form of nutritional anemia. Jcm free fulltext the effect of intraoperative ferric.
1477 622 1272 176 1175 1009 189 137 1489 794 1445 290 1236 593 77 1348 60 558 1188 575 992 1142 314 1055 1329 337 467 124 331 962 1315